Effective January 1, 2026, oncology-related medications for Commercial and Medicare Part B may be subject to updated prior authorization requirements. Visit the Evolent website to review the oncology-related medications policies.
Blue Shield Medicare plans follow Medicare guidelines for risk allocation and Medicare national and local coverage guidelines. If there is not a fully established or there is an absence of any applicable Medicare statute, regulation, guideline, Blue Shield Medicare medication policies will be used to determine medical necessity.
View the Blue Shield Medicare Part B medication policies:
Part B drugs may be subject to step therapy. View the Part B Step Therapy criteria:
- Medicare PPO Part B step therapy criteria (PDF, 134 KB)
Medical Benefit drug policies for Commercial plans
- Policy Name
- abaloparatide (Tymlos)
- abatacept (Orencia), intravenous
- abatacept (Orencia), subcutaneous
- abobotulinumtoxinA (Dysport)
- adalimumab (Humira)
- adalimumab-aacf (Idacio)
- adalimumab-aaty (Yuflyma)
- adalimumab-adaz (Hyrimoz)
- adalimumab-adbm (Cyltezo)
- adalimumab-afzb (Abrilada)
- adalimumab-aqvh (Yusimry)
- adalimumab-bwwd (Hadlima)
- adalimumab-fkjp (Hulio)
- adalimumab-ryvk (Simlandi)
- ADAMTS13, recombinant-krhn (Adzynma)
- ado-trastuzumab emtansine (Kadcyla)
- afamelanotide (Scenesse)
- afamitresgene autoleucel (Tecelra)
- aflibercept (Eylea, Eylea HD)
- aflibercept-ayyh (Pavblu)
- agalsidase beta (Fabrazyme)
- aldesleukin (Proleukin)
- alemtuzumab (Lemtrada)
- alglucosidase alfa (Lumizyme)
- alirocumab (Praluent)
- amivantamab-vmjw (Rybrevant)
- anakinra (Kineret)
- anifrolumab-fnia (Saphnelo)
- antihemophilic factor, human (Koate)
- antihemophilic factor, human, method m, monoclonal purified (Hemofil M)
- antihemophilic factor, recombinant (Advate)
- antihemophilic factor, recombinant (Kogenate FS)
- antihemophilic factor, recombinant (KOVALTRY)
- antihemophilic factor, recombinant (NovoEight)
- antihemophilic factor, recombinant (NUWIQ)
- antihemophilic factor, recombinant (Xyntha Solofuse)
- antihemophilic factor, recombinant (Xyntha)
- antihemophilic factor, recombinant, Fc fusion protein (ELOCTATE)
- antihemophilic factor, recombinant, Fc-VWF-XTEN fusion protein-ehtl (ALTUVIIIO)
- antihemophilic factor, recombinant, glycopegylated-exei (Esperoct)
- antihemophilic factor, recombinant, PEGylated (ADYNOVATE)
- antihemophilic factor, recombinant, PEGylated-aucl (Jivi)
- antihemophilic factor, recombinant, porcine sequence (OBIZUR)
- antihemophilic factor, recombinant, single chain (AFSTYLA)
- antihemophilic factor/von Willebrand factor complex, human (Alphanate)
- antihemophilic factor/von Willebrand factor complex, human (Humate-P)
- anti-inhibitor coagulant complex (FEIBA)
- Anti-thymocte globulin (Atgam)
- apomorphine hydrochloride (Apokyn)
- asfotase-alfa (Strensiq)
- asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze)
- atezolizumab (Tecentriq)
- atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza)
- atidarsagene autotemcel (Lenmeldy)
- avacincaptad pegol (Izervay)
- avalglucosidase alfa-ngpt (Nexviazyme)
- avelumab (Bavencio)
- axatilimab-csfr (Niktimvo)
- axicabtagene ciloleucel (Yescarta)
- azacitidine (Vidaza)
- belatacept (Nulojix)
- belimumab (Benlysta), intravenous
- belimumab (Benlysta), subcutaneous
- belinostat (Beleodaq)
- bendamustine (apotex)
- bendamustine (baxter)
- bendamustine (Belrapzo)
- bendamustine (Bendeka)
- bendamustine (Treanda)
- bendamustine (Vivimusta)
- benralizumab (Fasenra), autoinjector
- benralizumab (Fasenra), prefilled syringe
- beremagene geperpavec-svdt (Vyjuvek)
- betibeglogene autotemcel (Zynteglo)
- bevacizumab (Avastin)
- bevacizumab-adcd (Vegzelma)
- bevacizumab-awwb (Mvasi)
- bevacizumab-bvzr (Zirabev)
- bevacizumab-maly (Alymsys)
- bimatoprost implant (Durysta)
- blinatumomab (Blincyto)
- bortezomib (Velcade)
- bremelanotide (Vyleesi)
- brentuximab (Adcetris)
- brexucabtagene autoleucel (Tecartus)
- brodalumab (Siliq)
- brolucizumab-dbll (Beovu)
- burosumab-twza (Crysvita)
- C1 esterase inhibitor (Berinert)
- C1 esterase inhibitor (Cinryze)
- C1 esterase inhibitor (Haegarda)
- C1 esterase inhibitor (Ruconest)
- cabazitaxel (Jevtana)
- calasparagasepegol-mknl (Asparlas)
- canakinumab (Ilaris)
- cantharidin (Ycanth)
- caplacizumab-yhdp (Cablivi), subsequent doses
- capsaicin patch (Qutenza)
- carfilzomib (Kyprolis)
- casimersen (Amondys 45)
- cemiplimab-rwlc (Libtayo)
- cerliponase alfa (Brineura)
- certolizumab pegol (Cimzia), prefilled syringe
- certolizumab pegol (Cimzia), vials
- cetuximab (Erbitux)
- ciltacabtagene autoleucel (Carvykti)
- cipaglucosidase alfa-atga (Pombiliti)
- clofarabine (Clolar)
- coagulation factor IX, human (AlphaNine SD)
- coagulation factor IX, recombinant (BeneFIX)
- coagulation factor IX, recombinant (Ixinity)
- coagulation factor IX, recombinant (Recombinate)
- coagulation factor IX, recombinant (RIXUBIS)
- coagulation factor IX, recombinant, albumin fusion protein (Idelvion)
- coagulation factor IX, recombinant, Fc fusion protein (Alprolix)
- coagulation factor IX, recombinant, GlycoPEGylated (Rebinyn)
- coagulation factor VIIa, recombinant (NovoSeven)
- coagulation factor VIIa, recombinant-jncw (SEVENFACT)
- coagulation factor X, human (Coagadex)
- coagulation factor XIII A-subunit, recombinant (Tretten)
- collagenase clostridium histolyticum (Xiaflex)
- corticotropin (Acthar)
- corticotropin (Purified Cortropin Gel)
- crizanlizumab-tmca (Adakveo)
- crovalimab-akkz (Piasky)
- cytomegalovirus immune globulin intravenous, human (Cytogam)
- daratumumab (Darzalex)
- daratumumab hyaluronidase-fihj (Darzalex Faspro)
- darbepoetin alfa (Aranesp)
- datopotamab deruxtecan-dlnk (Datroway)
- daunorubicin cytarabine liposome (Vyxeos)
- daxibotulinumtoxinA-lanm (Daxxify)
- decitabine (Dacogen)
- defibrotide (Defitelio)
- degarelix (Firmagon)
- delandistrogene moxeparvovec-rokl (Elevidys)
- denosumab (Prolia)
- denosumab (Xgeva)
- dexamethasone intravitreal implant (Ozurdex)
- dinutuximab (Unituxin)
- donanemab-azbt (Kisunla)
- dostarlimab-gxly (Jemperli)
- dupilumab (Dupixent)
- durvalumab (Imfinzi)
- ecallantide (Kalbitor)
- eculizumab (Soliris)
- edaravone (Radicava)
- efgartigimod alfa-fcab (Vyvgart)
- efgartigimod alfa-fcab and hyaluronidase-qvfc (Vyvgart Hytrulo)
- eflapegrastim-xnst (Rolvedon)
- elapegademase-lvlr (Revcovi)
- elivaldogene autotemcel (Skysona)
- elosulfase alfa (Vimizim)
- elotuzumab (Empliciti)
- elranatamab-bcmm (Elrexfio)
- emapalumab-lzsg (Gamifant)
- emicizumab-kxwh (Hemlibra)
- enfortumab vedotin-ejfv (Padcev)
- epcoritamab-bysp (Epkinly)
- epoetin alfa (Epogen, Procrit)
- epoetin alfa-eobx (Retacrit)
- epoprostenol (Flolan, Veletri)
- eptinezumab-jjmr (Vyepti)
- erenumab-aoooe (Aimovig)
- eribulin (Halaven)
- esketamine (Spravato)
- etanercept (Enbrel)
- eteplirsen (Exondys 51)
- etranacogene-dezaparvovec (Hemgenix)
- evinacumab-dgnb (Evkeeza)
- evolucumab (Repatha)
- exagamglogene autotemcel (Casgevy)
- factor IX complex (Profilnine SD)
- factor XIII concentrate, human (Corifact)
- fam-trastuzumab deruxtecan-nxki (Enhertu)
- faricimab-svoa (Vabysmo)
- fecal microbiota live-jslm (Rebyota)
- ferric carboxymaltose (Injectafer)
- ferric derisomaltose (Monoferric)
- fibrinogen concentrate, human (RiaSTAP)
- fibrinogen, human (Fibryga)
- fidanacogene-elaparvovec-dzkt (Beqvez)
- filgrastim (Neupogen)
- filgrastim-aafi (Nivestym)
- filgrastim-ayow (Releuko)
- filgrastim-sndz (Zarxio)
- filgrastim-txid (Nypozi)
- fluocinolone acetonide intravitreal implant (Iluvien, Retisert, Yutiq)
- foscarbidopa and foslevodopa (Vyalev)
- fosdenopterin (Nulibry)
- fremanezumab-vfrm (Ajovy)
- fulvestrant (Faslodex)
- galcanezumab-gnlm (Emgality)
- galsulfase (Naglazyme)
- gemtuzumab ozogamicin (Mylotarg)
- givosiran (Givlaari)
- glatiramer (Copaxone, Glatopa)
- glofitamab-gxbm (Columvi)
- golimumab (Simponi Aria)
- golimumab (Simponi)
- golodirsen (Vyondys 53)
- grass pollens allergen extract (Oralair)
- growth hormone
- guselkumab (Tremfya), intravenous
- guselkumab (Tremfya), subcutaneous
- histrelin implant (Supprelin LA)
- house dust mite allergen extract (Odactra)
- hyaluronan (Hymovis)
- hyaluronan (Monovisc)
- hylan G-F 20 (Synvisc One)
- hylan G-F 20 (Synvisc)
- ibalizumab-uiyk (Trogarzo)
- icatibant (Firazyr)
- idecabtagene vicleucel (Abecma)
- idursulfase (Elaprase)
- imetelstat (Rytelo)
- imiglucerase (Cerezyme)
- immune globulin intravenous
- immune globulin intravenous, human (Bivigam)
- immune globulin intravenous, human (Flebogamma DIF)
- immune globulin intravenous, human (Gammagard liquid)
- immune globulin intravenous, human (Gammagard S/D)
- immune globulin intravenous, human (Gammaked)
- immune globulin intravenous, human (Gammaplex)
- immune globulin intravenous, human (Gamunex-C)
- immune globulin intravenous, human (Octagam)
- immune globulin intravenous, human (Privigen)
- immune globulin intravenous, human-ifas (Panzyga)
- immune globulin intravenous, human-slra (Asceniv)
- immune globulin intravenous, human-stwk (Alyglo)
- immune globulin subcutaneous
- immune globulin subcutaneous, human (Cuvitru)
- immune globulin subcutaneous, human (Gammagard liquid)
- immune globulin subcutaneous, human (Gammaked)
- immune globulin subcutaneous, human (Gamunex-C)
- immune globulin subcutaneous, human (Hizentra)
- immune globulin subcutaneous, human with recombinant human, hyaluronidase (Hyqvia)
- immune globulin subcutaneous, human-hipp (Cutaquig)
- immune globulin subcutaneous, human-klhw (Xembify )
- inclisiran (Leqvio)
- incobotulinumtoxinA (Xeomin)
- inebilizumab-cdon (Uplizna)
- infliximab (Remicade)
- Infliximab-abda (Renflexis)
- Infliximab-axxq (Avsola)
- Infliximab-dyyb (Inflectra)
- inotersen (Tegsedi)
- inotuzumab ozogamicin (Besponsa)
- interferon beta-1a (Avonex)
- interferon beta-1b (Betaseron, Extavia)
- interferon gamma-1b (Actimmune)
- ipilimumab (Yervoy)
- irinotecan liposome (Onivyde)
- iron dextran (Infed)
- isatuximab-irfc (Sarclisa)
- isavuconazonium sulfate (Cresemba)
- IVIG
- ixabepilone (Ixempra)
- ixekizumab (Taltz)
- ketamine (Ketalar)
- lanadelumab-flyo (Takhzyro)
- lanreotide (Somatuline)
- laronidase (Aldurazyme)
- lecanemab-irmb (Leqembi)
- lenacapavir (Sunlenca)
- letermovir Injection (Prevymis)
- leuprolide (Camcevi)
- leuprolide acetate (Fensolvi)
- levoleucovorin (Fusilev)
- levoleucovorin (Khapzory)
- lifileucel (Amtagvi)
- lisocabtagene maraleucel (Breyanzi)
- lonapegsomatropin-tcgd (Skytrofa)
- loncastuximab tesirine-lpyl (Zynlonta)
- lovotibeglogene autotemcel (Lyfgenia)
- lumasiran (Oxlumo)
- lurbinectedin (Zepzelca)
- luspatercept-aamt (Reblozyl)
- lutetium Lu 177 dotatate (Lutathera)
- lutetium Lu 177 vipivotide tetraxetan (Pluvicto)
- margetuximab-cmkb (Margenza)
- marstacimab-hncq (Hympavzi)
- mecasermin (Increlex)
- melphalan (Hepzato)
- mepolizumab (Nucala), prefilled autoinjector and syringe
- mepolizumab (Nucala), vials
- methotrexate(Otrexup, Rasuvo, RediTrex), subcutaneous
- methoxy polyethylene glycol-epoetin beta (Mircera)
- methylnatrexone (Relistor)
- metreleptin (Myalept)
- miglustat (Opfolda)
- mirikizumab-mrkz (Omvoh), intravenous
- mirikizumab-mrkz (Omvoh), subcutaneous
- mirvetuximab soravtansine-gynx (Elahere)
- mogamulizumab-kpkc (Poteligeo)
- mosunetuzumab-axgb (Lunsumio)
- motixafortide (Aphexda)
- nadofaragene firadenovec-vncg (Adstiladrin)
- natalizumab (Tysabri)
- naxitamab-gqgk (Danyelza)
- necitumumab (Portrazza)
- nedosiran (Rivfloza), prefilled syringe
- nedosiran (Rivfloza), vials
- nemolizumab-ilto (Nemluvio)
- nivolumab (Opdivo)
- nivolumab and hyaluronidase-nvhy (Opdivo Qvantig)
- nivolumab and relatlimab-rmbw (Opdualag)
- nogapendekin alfa inbakicept-pmln (Anktiva)
- nusinersen (Spinraza)
- obecabtagene autoleucel (Aucatzyl)
- obinutuzumab (Gazyva)
- ocrelizumab (Ocrevus)
- ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)
- Octreotide (Sandostatin), intravenous
- octreotide (Sandostatin), subcutaneous
- Octreotide LAR (Sandostatin LAR)
- ofatumumab (Kesimpta)
- olipudase alfa-rpcp (Xenpozyme)
- omacetaxine (Synribo)
- omalizumab (Xolair)
- omidubicel-onlv (Omisirge)
- onabotulinumtoxinA (Botox)
- onasemnogene abeparvovecxioi (Zolgensma)
- paclitaxel protein-bound (Abraxane)
- palifermin (Kepivance)
- palivizumab (Synagis)
- panitumumab (Vectibix)
- pasireotide (Signifor LAR)
- pasireotide (Signifor)
- patisiran (Onpattro)
- peanut (Arachis hypogaea) Allergen Powder-dnfp (Palforzia)
- pegaspargase (Oncaspar)
- pegcetacoplan (Empaveli)
- pegcetacoplan injection (Syfovre)
- Pegfilgrastim (Neulasta)
- Pegfilgrastim-apgf (Nyvepria)
- Pegfilgrastim-bmez (Ziextenzo)
- Pegfilgrastim-cbqv (Udenyca)
- Pegfilgrastim-fpgk (Stimufend)
- Pegfilgrastim-jmdb (Fulphila)
- Pegfilgrastim-pbbk (Fylnetra)
- peginterferon beta-1a (Plegridy)
- pegloticase (Krystexxa)
- pegunigalsidase alfa-iwxj (Elfabrio)
- pegvaliase-pqpz (Palynziq)
- pegvisomant (Somavert)
- pembrolizumab (Keytruda)
- pemetrexed (Alimta, Pemfexy, Pemrydi RTU)
- peramivir (Rapivab)
- pertuzumab (Perjeta)
- pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo)
- plasminogen human-tvmh (Ryplazim)
- plerixafor (Mozobil)
- polatuzumab vedotin-piiq (Polivy)
- posaconazole injection (Noxafil)
- pozelimab-bbfg (Veopoz)
- pralatrexate (Folotyn)
- protein C concentrate, human (Ceprotin)
- radium Ra 223 dichloride (Xofigo)
- ramucirumab (Cyramza)
- ranibizumab (Lucentis)
- ranibizumab intravitreal implant (Susvimo)
- ranibizumab-eqrn (Cimerli)
- ranibizumab-nuna (Byooviz)
- ravulizumab-cwvz (Ultomiris)
- remestemcel-L-rknd (Ryoncil)
- reslizumab (Cinqair)
- retifanlimab-dlwr (Zynyz)
- rilonacept (Arcalyst)
- rimabotulinumtoxinB (Myobloc)
- risankizumab-rzaa (Skyrizi), intravenous
- risankizumab-rzaa (Skyrizi), subcutaneous
- rituximab (Rituximab)
- rituximab and hyaluronidase human (Rituxan Hycela)
- rituximab-abbs (Truxima)
- rituximab-arrx (Riabni)
- rituximab-pvvr (Ruxience)
- romidepsin (Istodax)
- romiplostim (Nplate)
- romosozumab-aqqg (Evenity)
- ropeginterferon alfa-2b-njft (Besremi)
- rozanolixizumab-noli (Rystiggo)
- sacituzumab govitecan-hziy (Trodelvy)
- sargramostim (Leukine)
- sarilumab (Kevzara)
- satralizumabmwge (Enspryng)
- SCIG
- sebelipase alfa (Kanuma)
- secukinumab (Cosentyx), intravenous
- secukinumab (Cosentyx), subcutaneous
- selexipag (Uptravi)
- self-administered drugs
- setmelanotide (Imcivree)
- short ragweed pollen allergen extract (Ragwitek)
- sildenafil (Revatio)
- siltuximab (Sylvant)
- sirolimus protein bound particles (Fyarro)
- site of care redirection
- sodium hyaluronate (Durolane)
- sodium hyaluronate (Euflexxa)
- sodium hyaluronate (Gel One)
- sodium hyaluronate (Gelsyn-3)
- sodium hyaluronate (GenVisc 850)
- sodium hyaluronate (Hyalgan)
- sodium hyaluronate (Orthovisc)
- sodium hyaluronate (Supartz FX)
- sodium hyaluronate (Synojoynt)
- sodium hyaluronate (Triluron)
- sodium hyaluronate (TriVisc)
- sodium hyaluronate (Visco-3)
- sodium thiosulfate injection (Pedmark)
- somatropin (Genotropin, Humatrope, Norditropin, Nutropin, Omnitrope, Saizen, Zorbtive, Zomacton)
- somatropin (Serostim)
- sotatercept-csrk (Winrevair)
- spesolimab-sbzo (Spevigo), 300mg subcutaneous
- spesolimab-sbzo (Spevigo), intravenous and 600 mg subcutaneous
- Sumatriptan(Imitrex, Zembrace SymTouch), subcutaneous
- sutimlimab-jome (Enjaymo)
- tafasitamab-cxix (Monjuvi)
- tagraxofusp- erzs (Elzonris)
- taliglucerase alfa (Elelyso)
- talimogene laherparepvec (Imlygic)
- talquetamab-tgvs (Talvey)
- tarlatamab-dlle (Imdelltra)
- tbo-filgrastim(Granix)
- tebentafusp-tebn (Kimmtrak)
- teclistamab-cqyv (Tecvayli)
- teduglutide (Gattex)
- temsirolimus (Torisel)
- teplizumab-mzwv (Tzield)
- teprotumumab-trbw (Tepezza)
- teriparatide (Forteo)
- tesamorelin acetate (Egrifta)
- testosterone cypionate (Azmiro)
- testosterone enanthate (Xyosted)
- testosterone pellets (Testopel)
- testosterone undecanoate (Aveed)
- tezepelumab-ekko (Tezspire)
- tezepelumab-ekko (Tezspire), prefilled pens
- tildrakizumab-asmn (Ilumya)
- timothy grass pollen allergen extract (Grastek)
- tisagenlecleucel (Kymriah)
- tislelizumab-jsgr (Tevimbra)
- tisotumab vedotin-tftv (Tivdak)
- tocilizumab (Actemra), intravenous
- tocilizumab (Actemra), subcutaneous
- tocilizumab-aazg (Tyenne), intravenous
- tocilizumab-aazg (Tyenne), subcutaneous
- tocilizumab-bavi (Tofidence), intravenous
- tofersen (Qalsody)
- toripalimab-tpzi (Loqtorzi)
- trabectedin (Yondelis)
- tralokinumab-ldrm (Adbry)
- trastuzumab and hyaluronidase-oysk (Herceptin Hylecta)
- trastuzumab-anns (Kanjinti)
- trastuzumab-dkst (Ogivri)
- trastuzumab-dttb (Ontruzant)
- trastuzumab-pkrb (Herzuma)
- trastuzumab-qyyp (Trazimera)
- trastuzumab-strf (Hercessi)
- travoprost intracameral implant (iDose TR)
- tremelimumab-actl (Imjudo)
- treprostinil (Remodulin)
- treprostinil (Tyvaso)
- trilaciclib (Cosela)
- triptorelin (Triptodur)
- ublituximab-xiiy (Briumvi)
- ustekinumab (Stelara), vials
- ustekinumab-aauz (Otulfi), intravenous
- ustekinumab-aekn (Selarsdi), intravenous
- ustekinumab-auub (Wezlana), intravenous
- ustekinumab-kfce (Yesintek), intravenous
- ustekinumab-stba (Steqeyma), intravenous
- ustekinumab-ttwe (Pyzchiva), intravenous
- valoctocogene roxaparvovec-rvox (Roctavian)
- vedolizumab (Entyvio)
- vedolizumab (Entyvio), subcutaneous
- velaglucerase alfa (VPRIV)
- velmanase alfa-tycv (Lamzede)
- vestronidase alfa (Mepsevii)
- viltolarsen (Viltepso)
- von willebrand factor, recombinant (Vonvendi)
- von Willebrand factor/coagulation factor VIII complex, Human (Wilate)
- voretigene neparvovec-rzyl (Luxturna)
- vosoritide (Voxzogo)
- vutrisiran (Amvuttra)
- zanidatamab-hrii (Ziihera)
- zenocutuzumab-zbco (Bizengri)
- ziconotide (Prialt)
- ziv-aflibercept (Zaltrap)
- zolbetuximab-clzb (Vyloy)
Medication policy user guide
This brief user guide describes our medication policy, explains terms used, and includes contact info for more information
About medication policy
Find out how our medication policy, which determines if a service will be covered by a plan, is reviewed and updated.
Drug formulary, policy and forms
Search our drug formulary database, get prior authorization forms, and find information on oral and topical drugs, home-injectable drugs and more.